Do lower thresholds for diagnosis of gestational diabetes have later benefits for mothers and babies?

Project Code: 10446052

Faculty: Liggins Institute

Department: Liggins Institute

Main Supervisor: Dist Prof Jane Harding

Principal investigator: Professor Caroline Crowther

Application open date: 22 Feb 2019

Application deadline:

Enrolment information: NZ Citizens, NZ Permanent Residents, International

Introduction

Women who develop diabetes in pregnancy are at risk of later type 2 diabetes and heart disease, and their babies are at risk of obesity and later diabetes.

The aim of the GEMS randomised trial is to find out the best way of diagnosing gestational diabetes to improve pregnancy and birth outcomes, but we also need to know if this has any later benefits for the mother or baby.

What we are looking for in a successful applicant

Masters or Honours degree or equivalent in a health or education-related discipline and a clinical background. Examples include (but are not limited to) obstetrics, midwifery, paediatrics, medicine, public health.

Objective

To determine in the GEMS cohort whether different thresholds for diagnosing gestational diabetes alter: 

i) Later health of the women

ii) Outcomes of subsequent pregnancies

ii) Growth, health and development of the children. 

Other information

Here is more information about the GEMS trial.

Here are links to the supervisors' biographies:

To find out more about what we do visit: https://www.auckland.ac.nz/en/liggins.html

Related opportunities